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Introduction. The verbal, eye, and motor components of Glasgow coma scale (GCS) may be inﬂuenced by poisoned patients’
behavior in an attempted suicide. So, the values of admission GCS and its components for outcomes prediction in mixed drugs
poisoningwereinvestigated.Materials and Methods.Afollowupstudydatawasperformedonpatientswithmixeddrugspoisoning.
Outcomes were recorded as without complications and with complications. Discrimination was evaluated by calculating the area
under the receiver operating characteristic curves (AUC). Results. There was a signiﬁcant diﬀerence between the mean value of
each component of GCS as well as the total GCS between patients with and without complication. Discrimination was best for
GCS (AUC: 0.933 ± 0.020) and verbal (0.932 ± 0.021), followed by motor (0.911 ± 0.025), then eye (0.89 ± 0.028). Conclusions.
Admission GCS and its components seem to be valuable in outcome prediction of patients with mixed drug poisoning.
1.Introduction
Glasgow coma scale (GCS) ﬁrst appeared in 1974 in reports
by Graham Teasdale and Bryan J. Jennet, both professors
of neurosurgery at the University of Glasgow [1]. GCS is
now used in several emergency departments as an indicator
for the status of the central nervous system regardless of
their primary etiology. Poisoning with drugs inﬂuences
the biochemical substances of the brain and causes brain
damage. This may change the level of consciousness as well.
The GCS has been performed for outcome and recovery
evaluation of patients admitted to an intensive care unit
(ICU) following drug overdose [2], for the mental status
evaluation of poisoning patients [3], the need for intubation
in patients with antidepressant poisoning [4], and for
predicting acute and delayed poisoning outcomes [5–10].
All previous studies showed that for the assessment of
complication and mortality, the GCS score provides the best
indicator in poisoned patients; however, no study were done
to show how predictive is the subset of GCS (eye, motor,
and verbal). Mixed drugs poisoning (MDP) is one of the
mostcommonreasonsforadmissioninthepoisoningunitof
our emergency department. Since the verbal, eye, and motor
components of GCS may be inﬂuenced by poisoned patients’
behavior in an attempted suicide, this study was designed to
evaluate the values of GCS and its components in outcomes
prediction of patients with MDP.
2.MaterialsandMethods
This is a prospective followup study which conducted at the
Poisoning Emergency Department of Noor University Medi-
cal Center, a main referral center of Isfahan Province, Iran.
T h ec e n t r ei sf a c i l i t a t e d ,s t a ﬀed, and designed exclusively
for the management of poisoned patients in our hospital.2 Critical Care Research and Practice
One hundred ﬁfty two patients with mixed drugs poisoning
(MDP) were hospitalized in the centre and followed over
time to measure the ﬁnal outcome. Patients transferred from
elsewhere and patients admitted after the ﬁrst 24 hours of
ingestion were excluded. Having 152 patients, we would be
able to estimate 95% conﬁdence interval for mean GCS
scores with 0.4 eﬀect size. The project was approved by
the Institutional Ethics Committee of Isfahan University
of Medical Sciences (IUMS) (Research Project Number,
386295).
Forallpatients,routinebiochemicaltestsweremeasured,
and usual treatments were continued. Trained medical
staﬀ prospectively recorded demographic data and clinical
readings of patients. The composite GCS, including eye,
motor,andverbalcomponentsweremeasuredonadmission.
GCS was determined based on three components: eyes
(four = opening spontaneously, three = opening to verbal
command, two = opening to pain, and one = no eye
opening), verbal (ﬁve = oriented, four = disoriented, three
= inappropriate words, two = incomprehensible sounds, and
one = no verbal response), and motor (six = obeys, ﬁve =
localizes pain, four = withdrawal, three = abnormal ﬂexion,
two = abnormal extension, and one = no motor response)
[11]. All other available data including toxic agent, gender,
and age were also recorded. The outcomes were followed
subsequently based on the chart and categorized as either
without complications; or with complications from minor to
severe (requiring intubation and ventilatory support). Since
two patients died and both of them had complications, they
included in the complication group. Data were presented as
mean ± SE or n (%) where appropriate. Two-tailed paired
t-test was performed to compare mean scores at the baseline
and after the treatment. Logistic regression was applied to
calculate odds ratio (OR) with 95% conﬁdence interval (CI)
to show how predictive is the subset of GCS (eye, motor, and
verbal). For each outcome measure and combination of GCS
components, we identiﬁed the optimal cutoﬀ point. The area
underthecurve(AUC)anditsstandarderrorwerecalculated
to measure the prognostic information provided by each
combination of GCS components. AUCs between 0.7 and
0.8 were classiﬁed as “acceptable” and between 0.8 and 0.9
as “excellent” discrimination [12]. Data were analyzed using
SPSSversion17.0(SPSSInc,Chicago,IL,USA)andMedCalc
(MedCalc Software Inc, Mariakerke, Belgium). P value less
than .05 was considered as statistically signiﬁcant results.
3. Results
Inthisstudy,152patientswithmixeddrugpoisoning(MDP)
w e r es t u d i e d .T h e r ew e r em o r em e n( n = 54) than women
(n = 98). The mean age was 24.89 ± 0.65 years, ranged
from 14 to 56 years. Patients were admitted to the hospital
early in the course of ingestion (161.99 ± 6.65 minutes). The
most frequently used drugs were benzodiazepines, pain relief
medications, and antidepressants drugs (Table 1).
Our ﬁndings indicated that 130 patients (85.5%) sur-
vived without complications, 20 patients (13.2%) survived
with complications, and two patients died (1.3%) (Table 2).
Table 1 :L i s to fd i ﬀerent medications taken by patients.
Drugs N
Benzodiazepines 96
Pain relief medications∗ 79
Antidepressants 58
Antihistamines 22
Antihypertensive 20
Opioids 15
Anti-convulsants 14
Hypoglycemic agents 4
Other medications 66
∗Pain relief medications including acetaminophen, Adult cold, Non-
steroidal anti-inﬂammatory drugs; N: number of patients.
Table 2: Outcomes distribution in patients with mixed drug
poisoning (MDP).
Outcomes Number (%)
Without complications 130 (85.5)
With Complications
Minor 10 (6.6)
Severe 12 (7.9)
The length of hospital stay in 26.3% of patients was more
than 24 hours.
There were signiﬁcant diﬀerence in mean value of each
component as well as total GCS between patients with and
without complication (P<. 0001) (Table 3). Patients with
complications had less verbal, eye, motor, and GCS scores
than others.
For eye, verbal, and motor variables, and the area under
ROC curve, sensitivity and speciﬁcity at the best cutoﬀ point
were determined and compared with GCS. Discrimination
was excellent for GCS as well as all components including
motor, eye, and verbal. There were no statistically signiﬁcant
diﬀerences among all components in terms of area under
ROC curve (Table 4).
Logistic regression results indicated that the chance of
complications is 44 times higher for patients with motor
score less than ﬁve in comparison with normal motor score.
It also showed that patients with a verbal score equal or less
than three had 90 times the risk of complications compared
with those with verbal score four. With respect to eye
component, the chance of complications is 52 times higher
for patients with eye score less than two in comparison with
normal eye score (score ≥ 3) (Table 5).
4. Discussion
In this study, the value of GCS and its components in
predicting outcome of patients with MDP were investigated.
Ourﬁndingsshowthemeanvalueofeachcomponentaswell
as total GCS in patients with MDP was strongly related with
outcomes. Patients without complications had greater mean
values than patients with complications. The prognosis inCritical Care Research and Practice 3
Table 3: The mean value of GCS and its components in patients with MDP with respect to outcomes.
Variable Outcomes Groups Mean ± SE Mean diﬀerence ± SE 95% CI of diﬀerence
Lower Upper
Motor without complication 5.75 ± 0.06 2.01 ± 0.29 1.41 2.62
complications 3.73 ± 0.28
Verbal without complication 4.38 ± 0.07 2.33 ± 0.19 1.95 2.72
complications 2.05 ± 0.22
Eye without complication 3.42 ± 0.06 1.59 ± 0.16 1.26 1.93
complications 1.82 ± 0.19
GCS without complication 13.56 ± 0.17 5.97 ± 0.46 5.05 6.89
complications 7.59 ± 0.52
MDP: mixed drug poisoning; SE: standard error of mean; CI: Conﬁdence Interval; N: number of patients.
Table 4: Areas under the ROC curves of each component as well as total GCS.
Component AUC ± SE (95% CI) Cutoﬀ point Sensitivity (95% CI) Speciﬁcity (95% CI)
Motor 0.911 ± 0.025 (0.85–0.95) equal or less than 5 90.91 (70.8–98.6) 81.54 (73.8–87.8)
Verbal 0.932 ± 0.021 (0.87–0.96) equal or less than 3 90.91 (70.8–98.6) 90.00 (83.5–94.6)
Eye 0.89 ± 0.028 (0.83–0.93) equal or less than 2 86.36 (65.1–96.9) 89.23 (82.6–94.0)
GCS 0.933 ± 0.020 (0.88–0.96) equal or less than 10 90.91 (70.8–98.6) 92.31 (86.3–96.2)
ROC: Receiver under Operating Curve; GCS: Glasgow Coma Scale; AUC: area under the curve; SE: Standard error of mean; CI: Conﬁdence Interval.
patients presenting with poisoning depends on the level of
consciousness on admission [13].
Although rapid changes in the level of consciousness
in poisoning cases may raise a question on the role of
admission GCS in predicting outcome, we showed that
admissionGCSaswellasitscomponentscanbevalidatedfor
poisoned patients with mixed drugs ingestion. Applicability
of GCS in outcome prediction of diﬀerent poisoning has
been evaluated previously. GCS has been shown to be an
eﬀective clinical parameter that helps clinicians to predict
the outcome of organophosphate poisoning cases in the
initial assessment [14–17]. GCS has been also used for
predicting neuropsychological sequels of carbon monoxide
(CO) poisoning [7, 10].
Our results showed patients with GCS equal or less
than 10 had higher chance of getting complications in
comparison with patients with GCS score more than 10.
Unverir et al. demonstrated that antidepressant-poisoned
patients with GCS scores of 8 or less were intubated more
frequently [4]. GCS less than eight had been more associated
with mortality in children presenting with poisoning or
intoxication [5]. Heyman et al. recommended that patients
with a GCS score of more than six, and who are not
intubated, may not need admission to an intensive care
unit in intentional drug overdose cases [18]. Hamad et
al. illustrated the patients with drugs overdose and a GCS
score of less than 13 needed admission to an ICU [19].
GCS score equal or less than 14 had been associated with
myocardial injury in CO poisoning [10]. Diﬀerence in GCS
score in diﬀerent studies may be due to diﬀerent toxic
agent studied, diﬀerent poisoned patient population, and
evaluating diﬀerent outcomes. Toxic agent [20–22], antidote
[23],andthekindofinterventionbydiﬀerentphysicians[24]
are also eﬀective variables at predicting outcome. Davies et
al. illustrated besides of GCS, the kind of pesticide aﬀected
the outcome in acute organophosphate (OP) poisoning [20].
The pattern of changing GCS score after using antidote for
outcome prediction may be another important issue [23].
Variability in agreement between physicians when mea-
suring the GCS is another concern that may limit its clinical
usefulness [25, 26]. The interobserver variability is high
when the scoring systems are not used on a regular basis,
thus aﬀecting the accuracy and reproducibility of the data
[27, 28]. This is potentially relevant in our study, as GCS
determination was performed by several physicians and,
before the study period, had not formed a routine part
of patient assessment. We tried to minimize variability
by having one person to coordinate the process of data
collection and, before the study, had our anesthesiologist or
toxicologist formally train our emergency physicians in the
assessmentofGCS.AllGCSdeterminationsweredetermined
by this group of physicians.
5. Conclusions
In conclusion, our results show admission GCS and its
components seem to be valuable prognostic tools in acute
mixed drug poisoning. Findings on the predictive ability of
GCS score and its components can help clinicians to better
identify patients who may develop complications.
There are also some limitations in our study.
(1) Our results may not be extrapolated to other insti-
tutions. It is a single-centre study, which may not be
representative of all patients.
(2) GCS measured at the time of admission may not
reﬂect completely unforeseen events that may be4 Critical Care Research and Practice
Table 5: Prediction of outcomes in patients with MDP.
Variable NBSE P value Unadjusted OR (95% CI) Adjusted OR∗ (95% CI)
Motor score
6 108 1 1
≤5 44 3.79 0.77 .000 44.16 (9.66–20.185) 41.16 (8.67–19.54)
Verbal Score
4 and 5 119 1 1
≤3 33 4.50 0.79 .000 90 (18.86–429.3) 153.26 (23.79–987.2)
Eye Score
3 and 4 119 1 1
≤2 33 3.96 0.68 .000 52.47 (13.76–200) 51.14 (12.59–207.7)
GCS Score
11–15 122 1 1
≤10 30 4.78 0.81 .000 120 (24.46–588) 198 (28.63–1370)
∗The OR was adjusted for age and gender.
MDP: mixed drug poisoning; N: Number of the patients; B:e s t i m a t e dc o e ﬃcient; SE: standard error of mean; OR: odds ratio; CI: Conﬁdence Interval; GCS:
Glasgow coma scale.
major determinants of outcome. A sequential evalu-
ation of GCS may yield greater accuracy [29].
(3) The overall number of our patients with complica-
tions or death was relatively small which may be
aﬀected power of prediction of complications by
GCS scores. Given the listed most common agents
of poisoning employed by the study population
(benzodiazepines, pain relief medications including
acetaminophen, etc.), it is likely that mortality and
serious complications were negligible. Also, most
of the previous studies have only included patients
admitted to an intensive care unit. In contrast, our
studyincludedallpoisonedpatientspresenting tothe
poisoning emergency department, which makes the
results more generalizable.
(4) Inourhospitalthereisnotatoxicologylab;therefore,
the toxicological screening was not carried out to
conﬁrm diﬀerent kind of toxic agents. The diagnosis
was based on history and clinical evaluation and
summary records which had been conﬁrmed by
our poisoning emergency department specialists.
Although “mixed drugs” toxicity has been taken, but
any single agent may alter the outcome should also
be considered.
(5) Lack of measuring intensity of treatment may be
aﬀected the rate of complications.
Therefore, we suggest performing a larger prospective
study of poisoned patients, comparing complication or
death prediction of GCS scores and its components which
measured over time.
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